Financhill

Annual Reports

Per Page: 24
Company
Score
Last Price
Annual Revenues
Last Price:
132.06
Annual Revenues:
6.83B
Return on Equity:
23.78%
Last Price:
46.45
Annual Revenues:
10.55B
Return on Equity:
-5.19%
Last Price:
29.09
Annual Revenues:
20.03B
Return on Equity:
11.72%
Last Price:
7.40
Annual Revenues:
20.03B
Return on Equity:
11.72%
Last Price:
135.56
Annual Revenues:
1.17B
Return on Equity:
25.53%
Last Price:
228.52
Annual Revenues:
391.04B
Return on Equity:
140.28%
Last Price:
15.51
Annual Revenues:
9.3B
Return on Equity:
10.29%
Last Price:
56.00
Annual Revenues:
32.24B
Return on Equity:
27.49%
Last Price:
171.73
Annual Revenues:
54.32B
Return on Equity:
58.92%
Last Price:
2.15
Annual Revenues:
15.98B
Return on Equity:
15.48%
Last Price:
133.26
Annual Revenues:
9.92B
Return on Equity:
22.05%
Last Price:
117.26
Annual Revenues:
40.11B
Return on Equity:
14.78%
Last Price:
25.31
Annual Revenues:
15.38B
Return on Equity:
5.08%
Last Price:
8.99
Annual Revenues:
5.47B
Return on Equity:
12.08%
Last Price:
0.47
Annual Revenues:
98.2B
Return on Equity:
9.32%
Last Price:
12.39
Annual Revenues:
98.2B
Return on Equity:
9.32%
Last Price:
98.59
Annual Revenues:
13.29B
Return on Equity:
29.78%
Last Price:
19.06
Annual Revenues:
79.24B
Return on Equity:
37.17%
Last Price:
112.56
Annual Revenues:
16.11B
Return on Equity:
16.92%
Last Price:
361.05
Annual Revenues:
64.9B
Return on Equity:
26%
Last Price:
504.44
Annual Revenues:
19.41B
Return on Equity:
34.74%
Last Price:
110.84
Annual Revenues:
23.2B
Return on Equity:
8.09%
Last Price:
213.96
Annual Revenues:
12.31B
Return on Equity:
4.67%
No results

Investing News

Will Walgreens Go Bust?

Will Walgreens Go Bust?

Walgreens Boots Alliance stands at a critical juncture in the company’s 170-year history with revenues of $147 billion but a market capitalization of just $7 billion. A heavily burdened balance sheet has been the prime culprit of the stock’s downfall but, under new CEO Tim Wentworth, management is undertaking an ambitious realignment aimed at stabilizing […]

Read Article

#1 Dividend King To Buy Next Month

#1 Dividend King To Buy Next Month

The demand for artificial intelligence and cloud computing is growing exponentially, but the data centers that power those technologies require massive amounts of energy. At the same time, more organizations are looking for renewable energy sources to meet zero emission initiatives. Brookfield Renewable Partners (NYSE: BEP) stands out as an interesting play in this area […]

Read Article

Is AMD Stock a Buy on the Dip?

Is AMD Stock a Buy on the Dip?

Shares of AI chip manufacturer Advanced Micro Devices (NASDAQ:AMD) have been flagging of late as investors begin to question the multiples at which some AI stocks trade. AMD shares are still up nearly 13% on a 12-month basis but have lost effectively flat for the year. Much of this can be attributed to a Q3 […]

Read Article

How High Can DocuSign Stock Go?

How High Can DocuSign Stock Go?

Renowned e-signature company DocuSign, Inc. (NASDAQ:DOCU) has got firmly back on track after some turbulence in 2021 and 2022 when the company’s share price declined by more than 75%. The recent stock performance has fared much better, begging the question where is the ceiling for this once hot stock? DocuSign Is a Leader In Fast-Growing […]

Read Article

The Bear Case for Selling Palantir: A Time to Take Profits?

The Bear Case for Selling Palantir: A Time to Take Profits?

Palantir Technologies (NYSE:PLTR) share price is making even the most bullish supporter scratch their heads about what to do next. With the stock up a staggering 266% in 2024, shareholders are riding a bullish AI wave that is seemingly unstoppable. But it’s not all unicorns and rainbows under the hood. A deeper dive into the […]

Read Article

4 Stocks Dominate Bill Gates’ $45 Billion Portfolio

4 Stocks Dominate Bill Gates’ $45 Billion Portfolio

The Bill & Melinda Gates Foundation is a philanthropic powerhouse that lists among its accomplishments the total eradication of two types of polio virus, improving agricultural outcomes in impoverished countries and delivering health services to millions worldwide. Making these initiatives possible is a $45 billion investment portfolio that generates the money needed to fund the […]

Read Article

More Investing News

The #1 Stock Analysis Tool to Make Smarter Buy and Sell Decisions

Get started at Financhill, the #1 investment research platform that is your one-stop shop for finding the best trade ideas today.

  • Top Rated Stock Ideas
    Financhill Stock Score is a proprietary stock rating engine that independently evaluates every company based on fundamental, technical, and sentiment criteria so you can find the highest rated stocks in the S&P 500, NASDAQ and NYSE.
  • Best Stock Tools Platform
    Whether you are looking for the best blue chip stocks, top dividend stocks, most shorted stocks, cheapest stocks today, highest dividend stocks or best stocks under $50, Financhill has got you covered and has so much more.
  • Stocks Set To Soar & Crash
    Financhill spots seasonal patterns in thousands of stocks so you can easily screen for the best stocks at this time of year. Want to know what stocks could rise 11% over the next 7 weeks with 91% accuracy based on past history? Our Seasonality Screener will surface the hottest stocks right now.
Learn More

Featured in:

CNBC
The Wall Street Journal
Chicago Tribune
Barrons
MSN
Reuters